Embark Veterinary
Embark: Comprehensive dog DNA testing and veterinary services for informed pet care.
Founded
2015Embark: Comprehensive dog DNA testing and veterinary services for informed pet care.
Founded with a mission to improve the lives of dogs and their owners through advanced genetic testing, Embark Veterinary offers comprehensive dog DNA tests. Their core vision is to empower pet owners with detailed insights into their dog's breed, ancestry, and health, enabling informed care decisions. The company provides various DNA testing products, including Breed + Health Dog DNA Tests and Breed ID Dog DNA Tests, which are accessible through their online platform. Embark focuses on the pet care market, particularly targeting dog owners who seek to understand their pets better.
Notable figures associated with Embark Veterinary include co-founders Ryan and Adam Boyko, who have backgrounds in canine genetics. The company has garnered significant attention and investment from prominent venture capital firms. Key achievements include receiving over 20,000 five-star reviews and being recognized as a top gift by New York Magazine. Embark's impact is evident in the enhanced understanding and care it facilitates for dogs, contributing to the well-being of pets and peace of mind for their owners.
Companies similar to Embark Veterinary include Canines, AnimalBiome, MySimplePetLab and PetDx.
Embark Veterinary was founded in 2015.
Embark Veterinary's headquarters is located in Boston, MA, US.
Embark Veterinary's most recent funding round was for $75M (USD) in July 2021.
As of Jul 26, 2021, Embark Veterinary has disclosed funding of $94.3M (USD). Undisclosed round amounts are excluded.
Embark Veterinary has 185 employees as of Feb 5, 2024.
PetDx
